Coulson, A. B., Royle, K., Pawlyn, C., Cairns, D. A., Hockaday, A., Bird, J., Bowcock, S., Kaiser, M., de Tute, R., Rabin, N., Boyd, K., Jones, J., Parrish, C., Gardner, H., Meads, D., Dawkins, B., Olivier, C., Henderson, R., Best, P., Owen, R., Jenner, M., Kishore, B., Drayson, M., Jackson, G., & Cook, G. (2022). frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial. BMJ open, 12(6), . http://access.bl.uk/ark:/81055/vdc_100156684334.0x000010